[HTML][HTML] Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy

WE Sweeney, ED Avner - Pediatric research, 2014 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive
polycystic kidney disease (ARPKD) are significant causes of morbidity and mortality in …

[HTML][HTML] Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy

WE Sweeney Jr, ED Avner - Pediatric research, 2014 - ncbi.nlm.nih.gov
ADPKD and ARPKD are a significant cause of morbidity and mortality in children and young
adults. ADPKD with an incidence of 1: 400–1,000 affects over 13 million individuals …

Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

WE Sweeney Jr, ED Avner - Pediatric Research, 2013 - europepmc.org
ADPKD and ARPKD are a significant cause of morbidity and mortality in children and young
adults. ADPKD with an incidence of 1: 400–1,000 affects over 13 million individuals …

Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy

WE Sweeney Jr, ED Avner - Pediatric research, 2014 - pubmed.ncbi.nlm.nih.gov
Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive
polycystic kidney disease (ARPKD) are significant causes of morbidity and mortality in …

Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

WE Sweeney Jr, ED Avner - Pediatric Research, 2013 - europepmc.org
ADPKD and ARPKD are a significant cause of morbidity and mortality in children and young
adults. ADPKD with an incidence of 1: 400–1,000 affects over 13 million individuals …